THE ROLE OF IL17RD AND THE IL23-1L17 PATHWAY IN CROHN'S DISEASE
    2.
    发明申请
    THE ROLE OF IL17RD AND THE IL23-1L17 PATHWAY IN CROHN'S DISEASE 审中-公开
    IL17RD和IL23-1L17途径在CROHN病中的作用

    公开(公告)号:US20110177969A1

    公开(公告)日:2011-07-21

    申请号:US13121929

    申请日:2009-10-01

    IPC分类号: C12Q1/68 C40B30/04

    CPC分类号: C12Q1/6883 C12Q2600/156

    摘要: The present invention relates to methods of diagnosing susceptibility to Crohn's Diseaese by determining the presence or absence of susceptibility variants at the IL17RD locus. in one embodiment, the present invention provides a method of diagnosing and/or predicting susceptibility to Crohn's Disease by determining the presence or absence of an interaction between IL17RD Block 2 Haplotype 2 and IL23R Block 2 Haplotype 2 and/or IL12RB2 Haplotype 4, where the presence of an interaction between IL17RD Block 2 Haplotype 2 and IL23R Block 2 Haplotype 2 and/or IL12RB2 Haplotype 4 is indicative of susceptibility to Crohn's Disease.

    摘要翻译: 本发明涉及通过测定IL17RD基因座上易感性变体的存在或不存在来诊断对克罗恩病的易感性的方法。 在一个实施方案中,本发明提供了诊断和/或预测对克罗恩病的易感性的方法,其通过确定IL17RD Block 2单倍型2和IL23R Block 2单倍型2和/或IL12RB2单倍型4之间存在或不存在相互作用,其中 IL17RD Block 2单倍型2和IL23R Block 2之间的相互作用存在单倍型2和/或IL12RB2单倍型4表示对克罗恩病的易感性。